GLP-1 use rising rapidly among US adolescents and young adults, study finds
GLP-1 weight-loss medications are seeing a rapid increase in use among children, adolescents, and young adults across the US and globally.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A new study indicates that GLP-1 use is rising rapidly among adolescents and young adults in the United States. In the UK, state-funded weight-loss injections are becoming available to children as young as 12.
Similar trends are appearing in the UAE, where parents are increasingly seeking these injections for their children. Coverage from Medical Xpress and Gizmodo highlights Ozempic's role as a go-to treatment for teens.
The American Journal of Managed Care® (AJMC®) notes a specific correlation between the climbing use of GLP-1s in youth and a decline in bariatric surgery rates. Future developments involve the integration of these treatments into state-funded healthcare for younger demographics and the continued shift away from surgical interventions for weight loss.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 42m ago.
Quick answers
Which age groups are increasingly using GLP-1 medications?
Usage is rising among US adolescents and young adults, and state-funded jabs in some regions are available to children as young as 12.
How has this trend affected bariatric surgery?
According to the American Journal of Managed Care®, bariatric surgery rates are falling as GLP-1 use in youth climbs.
In which countries is this trend being reported?
Coverage identifies this trend in the United States, the UAE, and the UK.
Coverage (5)
- UAE parents increasingly seek weight-loss injections for children amid GLP-1 buzz Khaleej Times · 1d ago
- GLP-1 Use in Youth Climbs as Bariatric Surgery Rates Fall The American Journal of Managed Care® (AJMC®) · 1d ago
- Children as young as 12 to get state-funded weight-loss jabs The Times · 1d ago
- Ozempic Is Quietly Becoming the Go-to Weight Loss Treatment for Teens Gizmodo · 1d ago
- GLP-1 use rising rapidly among US adolescents and young adults, study finds Medical Xpress · 1d ago broke it first
People, places & organizations
Topics
Related trends
Novo sues Lilly, claiming misleading ads in weight-loss drug battle
Novo Nordisk has filed a lawsuit against Eli Lilly over allegations of false and misleading advertising regarding weight-loss drug efficacy.
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo Nordisk has filed a lawsuit against Eli Lilly, alleging the company used deceptive and false advertising regarding GLP-1 weight-loss medications.
Georgia woman part of lawsuit claiming link between GLP-1 weight loss drugs and blindness - WSB-TV
New legal actions and medical analyses are linking GLP-1 weight loss medications to a rare condition causing sudden, permanent vision loss.
This GLP-1 retreat changed how I think about weight loss
From luxury retreats to clinical meta-analyses, GLP-1 weight loss medications are sparking new debates on health and psychological impact.
24 GLP-1 Users Reveal The Good, The Bad, And The Shocking Side Effects
GLP-1 weight-loss medications are seeing a massive surge in adoption, sparking debates over side effects and social disclosure.
New study links ADHD symptoms in boys and addictive social media use
A new study suggests a link between addictive social media use in adolescent boys and the development or worsening of ADHD symptoms.